Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Atomoxetine
Treatment for ADHD
Typical Dosage: 40-100mg daily
Effectiveness
60%
Safety Score
65%
Clinical Trials
136
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
40-100mg daily
Time to Effect
2-4 weeks for initial effects, 6-12 weeks for full effect
Treatment Duration
Long-term (as needed)
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
7(Treat 7 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$600
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$850
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$21,250/QALY
QALYs Gained
0.04
Outcome-Based Costs
Cost per Responder
$1,888.89
Cost per Remission
$4,250
Atomoxetine Outcomes
for ADHD
Efficacy Outcomes
Overall Effectiveness
+60%
Response Rate
+45%
Remission Rate
+20%
Common Side Effects
Nausea/vomiting/abdominal pain
+15%
Insomnia
+12%
Dry mouth
+10%
Headache
+10%
Decreased appetite
+8%
Increased heart rate/blood pressure
+5%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
3 active trials recruiting for Atomoxetine in ADHD
Role of Coenzyme Q in ADHD in Children
NCT04216186RECRUITINGPHASE3
40 participants
INTERVENTIONAL
Tanta, Egypt
Started: Nov 1, 2018
Evaluating the Efficacy of Atomoxetine in Reducing Primary Nocturnal Enuresis in Children With ADHD: A Randomized, Placebo-Controlled Study
NCT06841666NOT YET RECRUITINGEARLY_PHASE1
100 participants
INTERVENTIONAL
Started: Feb 28, 2025
Black Seed Oil in ADHD
NCT06542887NOT YET RECRUITINGPHASE2
60 participants
INTERVENTIONAL
Started: Oct 1, 2024
Completed Clinical Trials
13 completed trials for Atomoxetine in ADHD
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
NCT00181766COMPLETEDPHASE4
45 participants
INTERVENTIONAL
Cambridge, United States
Started: Dec 1, 2003
Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy
NCT00181948COMPLETEDPHASE4
30 participants
INTERVENTIONAL
Cambridge, United States
Started: Sep 1, 2004
Concerta Treatment in Adults With ADHD NOS
NCT00181740COMPLETEDPHASE4
30 participants
INTERVENTIONAL
Cambridge, United States
Started: Dec 1, 2003
Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine
NCT00938743COMPLETEDPHASE4
50 participants
INTERVENTIONAL
Mannheim, Germany
Started: Jan 1, 2008
Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD
NCT03661788COMPLETEDPHASE4
38 participants
INTERVENTIONAL
Aachen, Germany
Started: May 1, 2016
Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)
NCT00190736COMPLETEDPHASE4
440 participants
INTERVENTIONAL
Lafayette, United States +18 more
Started: Sep 1, 2004
Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)
NCT00760747COMPLETEDPHASE4
112 participants
INTERVENTIONAL
Milton, Australia +5 more
Started: Sep 1, 2008
A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder
NCT00969618COMPLETEDPHASE3
211 participants
INTERVENTIONAL
Aichi, Japan +11 more
Started: Nov 1, 2009
A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00700427COMPLETEDPHASE3
2.02K participants
INTERVENTIONAL
Vienna, Austria +55 more
Started: Jun 1, 2008
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
NCT00417794COMPLETEDPHASE1
38 participants
INTERVENTIONAL
Oklahoma City, United States
Started: Aug 1, 2005
Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility
NCT00953862COMPLETEDNA
18 participants
INTERVENTIONAL
Started: Jul 1, 2005
Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00218543COMPLETEDPHASE2
20 participants
INTERVENTIONAL
New York, United States
Started: Jun 1, 2004
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
NCT00585910COMPLETEDPHASE4
94 participants
INTERVENTIONAL
Cambridge, United States
Started: Jan 1, 2004
Showing 20 of 136 total trials